Skip to main content
Log in

Usefulness of Tc-99m-GSA scintigraphy for liver surgery

  • Invited review article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Postoperative mortality remains high after hepatectomy compared with other types of surgery in patients who have cirrhosis or chronic hepatitis. Although there are several useful perioperative indicators of liver dysfunction, no standard markers are available to predict postoperative liver failure in patients with hepatocellular carcinoma (HCC) undergoing hepatectomy. The best preoperative method for evaluating the hepatic functional reserve of patients with HCC remains unclear, but technetium-99m diethylenetriamine pentaacetic acid galactosyl human serum albumin (99mTc-GSA) scintigraphy is a candidate. 99mTc-GSA is a liver scintigraphy agent that binds to the asialoglycoprotein receptor, and can be used to assess the functional hepatocyte mass and thus determine the hepatic functional reserve in various physiological and pathological states. The maximum removal rate of 99m Tc-GSA (GSA-Rmax) calculated by using a radiopharmacokinetic model is correlated with the severity of liver disease. There is also a significant difference of GSA-Rmax between patients with chronic hepatitis and persons with normal liver function. Regeneration of the remnant liver and recurrence of hepatitis C virus infection in the donor organ after living donor liver transplantation have also been investigated by 99mTc-GSA scintigraphy. This review discusses the usefulness of 99mTc-GSA scintigraphy for liver surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Morell AG, Irvine RA, Sternlieb I, Scheunberg IH, Ashwell G. Physical and chemical studies on ceruloplasmin. V. Metabolic studies on sialic acid-free ceruloplasmin in vivo. J Biol Chem. 1968;243:155–9.

    PubMed  CAS  Google Scholar 

  2. Pricer WE, Ashwell G. The binding of desialylated glycoproteins by plasma membranes of rat liver. J Biol Chem. 1971;246:4825–33.

    PubMed  CAS  Google Scholar 

  3. Burgess JB, Baenziger JU, Brown WR. Abnormal surface distribution of the human asialoglycoprotein receptor in cirrhosis. Hepatology. 1992;15:702–6.

    Article  PubMed  CAS  Google Scholar 

  4. Sawamura T, Kawasato S, Shiozaki Y, Sameshima Y, Nakada H, Tashiro Y. Decrease of a hepatic binding protein specific for asialoglycoproteins with accumulation of serum asialoglycoproteins in galactosamine-treated rats. Gastroenterology. 1981;81:527–33.

    PubMed  CAS  Google Scholar 

  5. Sawamura T, Nakada H, Hazama H, Shiozaki Y, Sameshima Y, Tashiro Y. Hyperasialoglycoproteinemia in patients with chronic liver diseases and/or liver cell carcinoma: asiaroglycoprotein receptor in cirrhosis and liver cell carcinoma. Gastroenterology. 1984;87:1217–21.

    PubMed  CAS  Google Scholar 

  6. Ha-Kawa SK, Tanaka Y, Hasebe S, Kuniyasu Y, Koizumi K, Ishii Y, et al. Compartmental analysis of asialoglycoprotein receptor scintigraphy for quantitative measurement of liver function: a multicentre study. Eur J Nucl Med. 1997;24:130–7.

    Article  PubMed  CAS  Google Scholar 

  7. Kwon AH, Ha-Kawa SK, Uetsuji S, Inoue T, Matsui Y, Kamiyama Y. Preoperative determination of the surgical procedure for hepatectomy using technetium-99m-galactosyl human serum albumin (99mTc-GSA) liver scintigraphy. Hepatology. 1997;25:426–9.

    Article  PubMed  CAS  Google Scholar 

  8. Wu J, Ishikawa N, Takeda T, Tanaka Y, Pan XQ, Sato M, et al. The functional hepatic volume assessed by 99mTc-GSA hepatic scintigraphy. Ann Nucl Med. 1995;9:229–35.

    Article  PubMed  CAS  Google Scholar 

  9. Ota T, Seki M, Morita R. Case report: focal fatty infiltration of the liver with accumulation defect on Tc-99m colloid and Tc-99m-GSA scintigraphy. Clin Radiol. 1997;52:399–401.

    Article  PubMed  CAS  Google Scholar 

  10. Tomiguchi S, Kira T, Oyama Y, Nabeshima M, Nakashima R, Tsuji A, et al. Correlation of Tc-99m GSA hepatic studies with biopsies in patients with chronic active hepatitis. Clin Nucl Med. 1995;20:717–20.

    Article  PubMed  CAS  Google Scholar 

  11. Kaibori M, Ha-Kawa SK, Uchida Y, Ishizaki M, Hijikawa T, Saito T, et al. Recurrent hepatitis C after living donor liver transplantation detected by Tc-99m GSA liver scintigraphy. Dig Dis Sci. 2006;51:2013–7.

    Article  PubMed  CAS  Google Scholar 

  12. Kaibori M, Ha-Kawa SK, Uchida Y, Ishizaki M, Saito T, Matsui K, et al. Liver regeneration in donors evaluated by Tc-99m-GSA scintigraphy after living donor liver transplantation. Dig Dis Sci. 2007;53:850–5.

    Article  PubMed  Google Scholar 

  13. Kaibori M, Ha-Kawa SK, Ishizaki M, Matsui K, Saito T, Kwon AH, et al. HA/GSA-Rmax ratio as a predictor of postoperative liver failure. World J Surg. 2008;32:2410–8.

    Article  PubMed  Google Scholar 

  14. Bosch X, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis. 1999;19:271–85.

    Article  PubMed  CAS  Google Scholar 

  15. Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC. Increase in primary liver cancer in the UK 1979–94. Lancet. 1997;350:1142–3.

    Article  PubMed  CAS  Google Scholar 

  16. EI-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340:745–50.

    Article  Google Scholar 

  17. Fan ST, Lai EC, Lo CM, Ng IO, Wong J. Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg. 1995;130:198–203.

    PubMed  CAS  Google Scholar 

  18. Nadig DE, Wada TP, Fairchild RB, Virgo KS, Johnson FE. Major hepatic resection. Arch Surg. 1997;132:115–9.

    PubMed  CAS  Google Scholar 

  19. Shimada M, Takenaka K, Fujiwara Y, Gion T, Shirabe K, Yanaga K, et al. Risk factors linked to postoperative morbidity in patients with hepatocellular carcinoma. Br J Surg. 1998;85:195–8.

    Article  PubMed  CAS  Google Scholar 

  20. Yeh CN, Chen MF, Lee WC, Jeng LB. Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. J Surg Oncol. 2002;81:195–202.

    Article  PubMed  Google Scholar 

  21. Benzoni E, Cojutti A, Lorenzin D, Adani GL, Baccarani U, Favero A, et al. Liver resective surgery: a multivariate analysis of postoperative outcome and complication. Langenbecks Arch Surg. 2007;392:45–54.

    Article  PubMed  Google Scholar 

  22. Redaelli CA, Dufour JF, Wagner M, Schilling M, Husler J, Krahenbuhl L, et al. Preoperative galactose elimination capacity predicts complications and survival after hepatic resection. Ann Surg. 2002;235:77–85.

    Article  PubMed  Google Scholar 

  23. Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology. 1996;111:1018–22.

    Article  PubMed  CAS  Google Scholar 

  24. Lau H, Man K, Fan ST, Yu WC, Lo CM, Wong J. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg. 1997;84:1255–9.

    Article  PubMed  CAS  Google Scholar 

  25. Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, et al. Surgery for small liver cancers. Semin Surg Oncol. 1993;9:298–304.

    Article  PubMed  CAS  Google Scholar 

  26. Pearl RH, Clowes GHA, Bosari S, McDermott WV, Menzoian JO, Love W, et al. Amino acid clearance in cirrhosis. A predictor of postoperative morbidity and mortality. Arch Surg. 1987;122:468–73.

    PubMed  CAS  Google Scholar 

  27. Gill RA, Goodman MW, Golfus GR, Onstad GR, Bubrick MP. Aminopyrine breath test predicts surgical risk for patients with liver disease. Ann Surg. 1983;198:701–4.

    Article  PubMed  CAS  Google Scholar 

  28. Kitai T, Inomoto T, Miwa M, Shikayama T. Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer. 2005;12:211–5.

    Article  PubMed  Google Scholar 

  29. Miyashiro I, Miyoshi N, Hiratsuka M, Kishi K, Yamada T, Ohue M, et al. Detection of sentinel node in gastric cancer surgery by indocyanine green fluorescence imaging: Comparison with infrared imaging. Ann Surg Oncol. 2008;15:1640–3.

    Article  PubMed  Google Scholar 

  30. Gotoh K, Yamada T, Ishikawa O, Takahashi H, Eguchi H, Yano M, et al. A novel image-guided surgery of hepatocellular carcinoma by indocyanine green fluorescence imaging navigation. J Surg Oncol. 2009;100:75–9.

    Article  PubMed  Google Scholar 

  31. Kaibori M, Ishizaki M, Matsui K, Kwon AH. Intraoperative indocyanine green fluorescent imaging for prevention of bile leakage after hepatic resection. Surgery. 2011;150(1):91–8.

    Google Scholar 

  32. Suou T, Yamada S, Hosho K, Yoshikawa N, Kawasaki H. Relationship between serum and hepatic 7s fragments of type IV collagen in chronic liver disease. Hepatology. 1996;23:1154–8.

    Article  PubMed  CAS  Google Scholar 

  33. Horii K, Kubo S, Hirohashi K, Kinoshita H. Changes in erythrocyte deformability after liver resection for hepatocellular carcinoma associated with chronic liver disease. World J Surg. 1999;25:85–90.

    Article  Google Scholar 

  34. Shimahara Y, Yamamoto N, Uyama N, Okuyama H, Momoi H, Kamikawa T, et al. Significance of serum type IV collagen level of hepatectomized patients with chronic liver damage. World J Surg. 2002;26:451–6.

    Article  PubMed  Google Scholar 

  35. Kubo S, Tsukamoto T, Hirohashi K, Tanaka H, Shuto T, Takemura S, et al. Appropriate surgical management of small hepatocellular carcinomas in patients infected with hepatitis C virus. World J Surg. 2003;27:437–42.

    Article  PubMed  Google Scholar 

  36. Yachida S, Wakabayashi H, Kokudo Y, Goda F, Okada S, Maeba T, et al. Measurement of serum hyaluronate as a predictor of human liver failure after major hepatectomy. World J Surg. 2000;24:359–64.

    Article  PubMed  CAS  Google Scholar 

  37. Mizuguchi T, Katsuramaki T, Nobuoka T, Kawamoto M, Oshima H, Kawasaki H, et al. Serum hyaluronate level for predicting subclinical liver dysfunction after hepatectomy. World J Surg. 2004;28:971–6.

    Article  PubMed  Google Scholar 

  38. Kanematsu T, Takenaka K, Matsumata T, Furuta T, Sugimachi K, Inokuchi K. Limited hepatic resection effective for selected cirrhotic patients with primary liver cancer. Ann Surg. 1984;199:51–6.

    Article  PubMed  CAS  Google Scholar 

  39. Kaibori M, Matsui Y, Hijikawa T, Uchida Y, Kwon AH, Kamiyama Y. Comparison of limited and anatomic hepatic resection for hepatocellular carcinoma with hepatitis C. Surgery. 2006;139:385–94.

    Article  PubMed  Google Scholar 

  40. Hayashi M, Fujii K, Kiuchi T, Uryuhara K, Kasahara M, Takatsuki M, et al. Effects of fatty infiltration of the graft on the outcome of living-related liver transplantation. Transpl Proc. 1999;31:403.

    Google Scholar 

  41. Ito T, Kiuchi T, Egawa H, Kaihara S, Oike F, Ogura Y, et al. Surgery-related morbidity in living donors of right lobe liver graft: lessons from the first 200 cases. Transplantation. 2003;76:158–63.

    Article  PubMed  Google Scholar 

  42. Cho JY, Suh K-S, Kwon CH, Yi NJ, Lee KU. Mild hepatic steatosis is not a major risk factor for hepatectomy and regenerative power is not impaired. Surgery. 2006;139:508–15.

    Article  PubMed  Google Scholar 

  43. Iwasaki M, Takada Y, Hayashi M, Minamiguchi S, Haga H, Maetani Y, et al. Noninvasive evaluation of graft steatosis in living donor liver transplantation. Transplantation. 2004;78:1501–5.

    Article  PubMed  Google Scholar 

  44. Ha-Kawa SK, Suga Y, Ikeda K, Nagata K, Murata T, Tanaka Y. Usefulness of blood disappearance corrected hepatic uptake ratio (LHL/HH) as a hepatic functional index using 99mTc-galactosyl serum albumin. Kakuigaku. 1993;30:1333–9. (in Japanese with English abstract).

    CAS  Google Scholar 

  45. Pomfret EA, Pomposelli JJ, Gordon FD, Erbay N, Lyn Price L, Lewis WD, et al. Liver regeneration and surgical outcome in donors of right-lobe liver grafts. Transplantation. 2003;76:5–10.

    Article  PubMed  Google Scholar 

  46. Humar A, Kosari K, Sielaff TD, Glessing B, Gomes M, Dietz C, et al. Liver regeneration after adult living donor and deceased donor split-liver transplants. Liver Transpl. 2004;10:374–8.

    Article  PubMed  Google Scholar 

  47. Kwon AH, Matsui Y, Ha-Kawa SK, Kamiyama Y. Functional hepatic volume measured by technetium-99m-galactosyl-human serum albumin liver scintigraphy: comparison between hepatocyte volume and liver volume by computed tomography. Am J Gastroenterol. 2001;96:541–6.

    Article  PubMed  CAS  Google Scholar 

  48. Baltz AC, Trotter JF. Living donor liver transplantation and hepatitis C. Clin Liver Dis. 2003;7:651–65.

    Article  PubMed  Google Scholar 

  49. Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med. 1996;334:815–20.

    Article  PubMed  CAS  Google Scholar 

  50. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology. 2002;122:889–96.

    Article  PubMed  Google Scholar 

  51. Berenguer M, Ferrell L, Watson J, Prieto M, Kim M, Rayón M, et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol. 2000;32:673–84.

    Article  PubMed  CAS  Google Scholar 

  52. Samuel D, Bizollon T, Feray C, Roche B, Ahmed SN, Lemonnier C, et al. Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study. Gastroenterology. 2003;124:642–50.

    Article  PubMed  CAS  Google Scholar 

  53. Kiuchi T, Uemoto S, Egawa H, Kaihara S, Oike F, Yokoi A, et al. Living donor liver transplantation in Kyoto, 2001. Clin Transpl. 2001;195–201.

  54. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696–9.

    Article  PubMed  CAS  Google Scholar 

  55. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996;24:289–93.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masaki Kaibori.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaibori, M., Ha-Kawa, S.K., Maehara, M. et al. Usefulness of Tc-99m-GSA scintigraphy for liver surgery. Ann Nucl Med 25, 593–602 (2011). https://doi.org/10.1007/s12149-011-0520-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-011-0520-0

Keywords

Navigation